Apoptosis in giant cell tumors of bone

Kurume Medical Journal

Volumn 47, Issue 2, 2000, Pages 125-134

  Kakizoe, Mitsuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Fas; Giant cell tumor; Protein synthesis inhibitor; Soluble fas

Indexed keywords

PRIMER DNA;

APOPTOSIS; ARTICLE; BONE TUMOR; GIANT CELL TUMOR; HUMAN; IMMUNOLOGY; NUCLEOTIDE SEQUENCE; PATHOLOGY;

APOPTOSIS; BASE SEQUENCE; BONE NEOPLASMS; DNA PRIMERS; GIANT CELL TUMORS; HUMANS;

EID: 0033660565     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.47.125     Document Type: Article

References (34)

1. Campanacci M. Giant cell tumor. In: Bone and Soft Tissue Tumors, ed. Campanacci M, Springer-Verlag, New York, pp117-151, 1990.
2. Jaffe HL, Lichtenstein L, and Portis RB. Giant cell tumor of bone. Its pathologic appearance, grading, supposed variants and treatments. Arch Pathol 1940; 30:993-1031.
3. Schajowicz F. Giant-cell tumor (osteoclastoma). In: Tumors and Tumorlike Lesions of Bone and Joints, ed. Schajowicz F, Springer-Verlag, New York, pp205-242, 1981.
4. Goldenberg RR, Campbell CJ, and Bonfiglio M. Giant-cell tumor of bone. An analysis of two hundred and eighteen cases. J Bone Joint Surg 1970; 52 [Am]:619-663.
5. Komiya S, Sasaguri Y, Inoue A, Nakashima M, Yamamoto S et al. Characterization of cells cultured from human giant-cell tumors of bone. Phenotypic relationship to the monocyte-macrophage and osteoclast. Clin Orthop 1990; 258:304-309.
6. Sasaguri Y, Komiya S, Sugama K, Suzuki K, Inoue A et al. Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumor of bone. Am J Pathol 1992; 141:611-621.
7. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-243.
8. Gavrieli Y, Shermen Y, and Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
9. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263:1759-1762.
10. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF et al. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries-association of acidic FGF with plaque microvessels and macrophages. J Clin Invest 1993; 92:2408-2418.
11. Hansen MB, Nielsen SE, and Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Method 1989; 119:203-210.
12. Blanco FJ, Ochs R, Scwartz H, and Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995; 146:75-85.
13. Arends MJ, and Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32:223-254.
14. Duvall E, and Wyllie AH. Death and the cell. Immunol Today 1986; 7:115-119.
15. Ucker PS. Death by suicide: one way to go in mammalian cellular development? The New Biologist 1991; 3:103-109.
16. Cohen JJ, and Duke RC. Glucocorticoid activation of calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 1984; 132:38-42.
17. ++ concentration. Arch Biochem Biophys 1989; 269:365-370.
18. Eastman A. Activation of programmed cell death by anti-cancer agents: cisplatin as a model system. Cancer Cells 1990; 2:275-280.
19. Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 1989; 49:5870-5878.
20. Meyn RE, Stephens LC, Ang KK, Hunter NR, Brock WA et al. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol 1993; 64:583-591.
21. Sellins KS, and Cohen JJ. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 1987; 139:3199-3206.
22. Sarraf CE, and Bowen ID. Kinetic studies on a murine sarcoma and an analysis of apoptosis. Br J Cancer 1986; 54:989-998.
23. Wyllie AH. The biology of cell death in tumors. Anticancer Res 1985; 5:131-136.
24. Wyllie AH, Morris RG, Smith AL, and Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142:67-77.
25. Neale SD, and Athanasou NA. Cytokine receptors on osteoclasts and macrophages/macrophage polykaryons. Tissue Antigens 1996; 48:394.
26. Suda T, Takahashi T, Goldstein P, and Nagata S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis family. Cell 1993; 75:1169-1178.
27. Tartaglia LA, Ayres TM, Wong GHW, and Goeddel DV. A novel domain within the 55kd TNF receptor signals cell death. Cell 1993; 74:845-853.
28. O'Keefe RJ, Teot LA, Singh D, Puzas JE, Rosier RN et al. Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study. Lab Invest 1997; 76:457-465.
29. + T cell-mediated cytotoxicity. J Immunol 1994; 152:1127-1133.
30. Wallach D. Preparations of lymphotoxin induce resistance to their own cytotoxic effect. J Immunol 1984; 132:2464-2469.
31. Yonehara S, Ishii A, and Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169:1747-1756.
32. Natoli G, Ianni A, Costanzo A, De Petrillo G, Hari I et al. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 1995; 11:1157-1164.
33. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA et al. The stress-activated protein kinase subfamily of c-jun kinases. Nature 1994; 369:156-160.
34. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380:75-79.